← Back to Search

Behavioral Intervention

Neurofeedback-based BCI for Attention Training

N/A
Recruiting
Research Sponsored by University of Rhode Island
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial aims to develop and test a new brain training tech to improve attention and treat mental disorders like anxiety, depression and addiction.

Who is the study for?
This trial is for adults over 18 without brain damage or diagnosed mental issues, who are physically able to push buttons or keys. It aims to help not just those with attention deficits but could also benefit individuals with anxiety, depression, and addiction.Check my eligibility
What is being tested?
The study tests three types of neurofeedback: adaptive (changes based on performance), sham (fake feedback), and nonadaptive (constant). The goal is to improve attention training techniques that may be used for various neurocognitive disorders.See study design
What are the potential side effects?
Since the interventions involve neurofeedback which doesn't introduce substances into the body, side effects might include discomfort from wearing equipment or psychological effects due to awareness of being monitored.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Accuracy of behavioral performance measured by push buttons in response to stimuli

Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: adaptive neurofeedbackActive Control1 Intervention
Both neural activity and accuracy of behavioral responses will be evaluated before and after a closed-loop adaptive neurofeedback protocol. In this method, the stimuli is changed using the upcoming neural activity and an adaptive algorithm.
Group II: nonadaptive neurofeedbackActive Control1 Intervention
Both neural activity and accuracy of behavioral responses will be evaluated before and after a closed-loop nonadaptive neurofeedback protocol. In this method, the stimuli is changed using the upcoming neural activity and an open-loop attention model of the corresponding human subject.
Group III: sham neurofeedbackPlacebo Group1 Intervention
Both neural activity and accuracy of behavioral responses will be evaluated before and after a closed-loop sham neurofeedback protocol.

Find a Location

Who is running the clinical trial?

University of Rhode IslandLead Sponsor
52 Previous Clinical Trials
22,146 Total Patients Enrolled

Media Library

Adaptive Neurofeedback (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05908253 — N/A
Neurofeedback Research Study Groups: adaptive neurofeedback, sham neurofeedback, nonadaptive neurofeedback
Neurofeedback Clinical Trial 2023: Adaptive Neurofeedback Highlights & Side Effects. Trial Name: NCT05908253 — N/A
Adaptive Neurofeedback (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05908253 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the age limit of this research exclude those younger than 55 years old?

"The eligible cohort of this clinical trial must have reached the age of consent and be under 70 years old."

Answered by AI

What qualifications must a potential participant possess to join this trial?

"To be eligible for this clinical trial, participants must have a diagnosis of neurofeedback and be between the ages 18 to 70. A total of 45 candidates will be accepted into the program."

Answered by AI

Is it still possible to join this scientific research project?

"According to clinicaltrials.gov, this trial is not presently enrolling patients; the initial posting date was July 1st 2023 and it last underwent revisions on June 7th of that year. However, there are 4 other studies actively recruiting at this time."

Answered by AI
~0 spots leftby Apr 2024